| Date | Time | Source | Headline | Symbol | Company |
| 06/08/2007 | 12:51PM | PR Newswire (US) | Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc. | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 06/05/2007 | 3:58PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2007 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 05/29/2007 | 12:00PM | PR Newswire (US) | Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 05/09/2007 | 10:00AM | PR Newswire (US) | Boston Life Sciences to Host 2007 1st Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 05/03/2007 | 10:30AM | PR Newswire (US) | Boston Life Sciences Raises $6 Million Through Issuance of a Convertible Promissory Note to a New Fund | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 05/01/2007 | 11:44AM | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 2007 Biotechnology Industry Organization's (BIO) Annual BIO International Conventio | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/17/2007 | 10:00AM | PR Newswire (US) | Boston Life Sciences Reports New Option Grants Under NASDAQ Market Rule 4350 | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/16/2007 | 12:57PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the Americ | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/16/2007 | 10:00AM | PR Newswire (US) | Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/12/2007 | 4:22PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces Data to be Presented on Cethrin(R) for Spinal Cord Injury at the 2007 American Association | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 04/02/2007 | 5:07PM | PR Newswire (US) | Boston Life Sciences, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/29/2007 | 11:45AM | PR Newswire (US) | Boston Life Sciences To Host 2006 4th Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/27/2007 | 11:33AM | PR Newswire (US) | Boston Life Sciences Completes Final License Fee Payment for Exclusive, Worldwide Rights to Develop and Commercialize Phase II S | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/26/2007 | 3:55PM | PR Newswire (US) | Boston Life Sciences Enters Into $15 Million Convertible Promissory Note Purchase Agreement and Amends Existing Promissory Notes | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/22/2007 | 11:25AM | PR Newswire (US) | Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 03/07/2007 | 11:00AM | PR Newswire (US) | Boston Life Sciences, Inc. To Present at the Sachs Associates 6th Annual North America Forum for Investing & Partnering in Biote | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/13/2007 | 2:55PM | PR Newswire (US) | Boston Life Sciences Issues Amended Promissory Notes for Up to an Additional $2 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/07/2007 | 10:28AM | PR Newswire (US) | Boston Life Sciences, Inc. to Participate in the 2007 BIO CEO & Investor Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/06/2007 | 2:43PM | PR Newswire (US) | Boston Life Sciences Announces the Appointment of Henry Brem, M.D. and Gary Frashier to the Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 02/01/2007 | 11:07AM | PR Newswire (US) | Boston Life Sciences Sponsors Movement Disorder Society's 1st Annual Neuroimaging in Parkinson's Disease Symposium | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 01/04/2007 | 9:26AM | PR Newswire (US) | Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exc | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 12/13/2006 | 1:32PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2006 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 11/06/2006 | 9:17AM | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the CIBC World Markets 17th Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 11/02/2006 | 12:39PM | PR Newswire (US) | Boston Life Sciences Issues Promissory Notes for Up to $8 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 10/31/2006 | 11:12AM | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Rodman & Renshaw Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 10/30/2006 | 4:21PM | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Mass Biotech Council's Mass Opportunities Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 09/25/2006 | 12:33PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 08/30/2006 | 11:10AM | PR Newswire (US) | Peter Savas, Chairman and CEO of Boston Life Sciences, Inc., Scheduled to Appear on New England Cable News 'New England Busines | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 08/10/2006 | 4:46PM | PR Newswire (US) | Boston Life Sciences, Inc. Announces the Issuance of a U.S. Patent Licensed to BLSI by Harvard et al that Covers Methods for th | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 07/27/2006 | 10:31AM | PR Newswire (US) | Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |